{"name":"Ying Liu","slug":"ying-liu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ropivacaine Infusion from ON-Q Pump","genericName":"Ropivacaine Infusion from ON-Q Pump","slug":"ropivacaine-infusion-from-on-q-pump","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Ropivacaine Infusion from ON-Q Pump","genericName":"Ropivacaine Infusion from ON-Q Pump","slug":"ropivacaine-infusion-from-on-q-pump","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNUVRmSm9zN2dpZlZjVnZUS0F4OWFwVnZmc09KR25PZndYMmlLa21pVERPQThpYTg0SFVDTWotUEl4UjFGVFVhQjEtQVNFczhya09zc09EYk9JWDdGZU1DMGxUSGdMNHA1dkJHUVh4YVVWTlJrXzd3NEd0TUxOenYyQWVJY2Vyei1wQmFOTXlETmxNUTRGM3BUeUlMYmdOanVwYmZ0eG1OVmp3SWxYYmVBOUI4NlMtMDdoLWxqREVpTEhXQW5lcHNoV1dlYlZiSjEwT0lKU25fOXZuTTEtbS1xaFptS0Q0RWxDYy1R?oc=5","date":"2025-05-29","type":"trial","source":"ACN Newswire","summary":"First patient dosed in YK012 trial-the world's first TCE therapy for primary membranous nephropathy - ACN Newswire","headline":"First patient dosed in YK012 trial-the world's first TCE therapy for primary membranous nephropathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5valBTdGw2d0lxMkZzaXQ1c20zbzlGUDBSY1FJdlUwdFAtRFdOZl9YXzAxM0FCWmVOaUprZ3p1Vm81dFdpMkxRV3RRZGQ1TEhXbWxudWVIV2RNeVhiN2s0?oc=5","date":"2025-04-10","type":"trial","source":"Nature","summary":"RNA-Seq transcriptome profiling reveals distinct immune response landscapes to identifying inflammation-related diagnostic markers in latent endometrial tuberculosis - Nature","headline":"RNA-Seq transcriptome profiling reveals distinct immune response landscapes to identifying inflammation-related diagnost","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBzaTZpXzQ0eHU5aXVZN1BTZmllQm5CcjVGUHZ5a2FRTmtQYkhEbVYxVGRTVGxNdnNEby1qUkE4cUJxOHhvc0lfaE02RnVldGhUbHFWV25RUHhwWE5EVTZZY1JBbGIxNWR6QjRLU1E0a19mQWx5cTNrUl8tWQ?oc=5","date":"2025-03-07","type":"pipeline","source":"Wiley","summary":"MTCH2 Suppresses Thermogenesis by Regulating Autophagy in Adipose Tissue - Wiley","headline":"MTCH2 Suppresses Thermogenesis by Regulating Autophagy in Adipose Tissue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFA5bVliTDlzUkE0TEZYaEZFZEh3ZVhXUnBmLXV0eE9LcVZLMWs3RFhlZ2hkM1liMDJ6d2xFQTN4WEo2eGVZckRkZ3k1MnJqY2NWOERxRVZoSjhXblV0RFpXaTNmcm5OLTdkTnU2Qm5qcC1ISjRmd04tbmJQcw?oc=5","date":"2025-02-14","type":"pipeline","source":"Wiley","summary":"Perillaldehyde Improves Parkinson-Like Deficits by Targeting G3BP Mediated Stress Granule Assembly in Preclinical Models - Wiley","headline":"Perillaldehyde Improves Parkinson-Like Deficits by Targeting G3BP Mediated Stress Granule Assembly in Preclinical Models","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE4tRkIzRE1XLWs5WnUtOGJOM2N1cER2SG9uWDlRVUtsSUU5ejR4RlJXS0lHdkh4UDFVSzRFS1A2OTNYMnN0bUJ5djlnc2Q3R3Nhdi1Ra3dxeDVkR2Qz?oc=5","date":"2024-09-19","type":"pipeline","source":"ACS Publications","summary":"Near-Infrared Emissive π-Conjugated Oligomer Nanoparticles for Three- and Four-Photon Deep-Brain Microscopic Imaging Beyond 1700 nm Excitation - ACS Publications","headline":"Near-Infrared Emissive π-Conjugated Oligomer Nanoparticles for Three- and Four-Photon Deep-Brain Microscopic Imaging Bey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOZ1hNZy0ySWtoZ3lIX2h6Z2xOLXhoQkk3Ry1qYmY2MHp2WmFDc2pPdGJ2RDV4ckdhOFBjck5XYzctd1VxanE0aUhOS1psX1QyU0xYSW9nRGJvUnp0dlVjN3p2SjU3VjZxdjI1T3BjS00zX0FjN2xqYnFvd2dkMEF0R01FemJuZW8yRjVlUnpCX21GeWY1SjdDcURVSFRMUQ?oc=5","date":"2024-06-25","type":"pipeline","source":"ScienceDirect.com","summary":"European Journal of Pharmaceutical Sciences | Vol 200, 1 September 2024 - ScienceDirect.com","headline":"European Journal of Pharmaceutical Sciences | Vol 200, 1 September 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1zYWhpU2RwbzN2bFRRX3NsV2lZWnZqQTItUWt4TEdtZHFncWJLRTVPN3hjQk03cm9yVmtaazVubXZHTVNzSmFhMVUyS1lWV0NPWVlVOHlCdFpHbjhp?oc=5","date":"2024-05-15","type":"pipeline","source":"EurekAlert!","summary":"Acta Pharmaceutica Sinica B Volume 14, Issue 5 Publishes - EurekAlert!","headline":"Acta Pharmaceutica Sinica B Volume 14, Issue 5 Publishes - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQT2swN3M5UjRXMWVpaVdFMEhNd1g0SldOaXNXdXVLbkplNEV0ZmZobDFNZE5tU3JfMlVPWm5PQTFRSUtZY2JGWXZnZ3dOcFRCYnJOeGVZUDRFT05yNmtVVEtrc0l1Nmt0ZGFlamMxX2ZCOGZSN3FmTHNEUFZmd0FGR0EyWTYzMWcyWHc?oc=5","date":"2024-05-07","type":"pipeline","source":"Packaging Gateway","summary":"Beyond the box with Blue Lake Packaging founder Ying Liu - Packaging Gateway","headline":"Beyond the box with Blue Lake Packaging founder Ying Liu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNZ1NiQlFsM05rWU5yMGx0SUZlQzI5TTJuTXc5V28zQXZzOVFWMm9jcExFOWs0bXpUSkxLNmJGNDgxUXFjY1UtOEpCME8weE9KeEJReXVhaklnZG9kdGNOT0JjcnhNTlJ0NTEtRDNiZGNFUWktM1VRNlNwWGdqdDZqdE8wSXBmSlhPeVV1SVNSMUVJb01u?oc=5","date":"2024-02-05","type":"pipeline","source":"Packaging Dive","summary":"From Apple to plastic-free living: Blue Lake Packaging founder describes business pivot - Packaging Dive","headline":"From Apple to plastic-free living: Blue Lake Packaging founder describes business pivot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxORTVhYkNseTFrMkpxUFV4MS1hOHhGTDFfWUtiVFdYZFJGWnUtRWg3anhpbWZ0OW9XeU9GSnVaRU1wUzFNd2U3Mml3WDh4dGtLaXhsVVFjNmY4ZGxIcWZyQ2hkSUtIYVVibnJzcWVYMTlzYWhtaktSeV9pelJWTk9xQlhoYzI5R1dpWi1LZlpuTFBpNmxMckVPNGRSZmdOSjdaVWM1ZjBBSkJRYU5YZ21lVkVmSzl6MlFCNWU1Q3FXaw?oc=5","date":"2023-08-16","type":"pipeline","source":"Fierce Pharma","summary":"J&J, Legend's myeloma CAR-T Carvykti not slowing down in the face of new bispecific: Legend exec - Fierce Pharma","headline":"J&J, Legend's myeloma CAR-T Carvykti not slowing down in the face of new bispecific: Legend exec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBFdXZOT0JrQWUwcV83eGVWQWZDSWFEWVZaMGp1SmJuM25tLWx6My1KdmpqX1RjSmRBbFZyazdOTlhTSFprLTV0cHVOd1o1OUVkQkVGdzFZN2lrZUJPR2JCUlF4c0hCMFl2Mk9tUlFvY09NQnpjR2VaN0E2MA?oc=5","date":"2022-06-28","type":"pipeline","source":"ScienceDirect.com","summary":"Preparation of meloxicam-salicylic acid co-crystal and its application in the treatment of rheumatoid arthritis - ScienceDirect.com","headline":"Preparation of meloxicam-salicylic acid co-crystal and its application in the treatment of rheumatoid arthritis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE44TkUwOTdKNDBuZnNMcHR0WGdOMTlwVzRtNGZzN1ZZdHhZbi1Fb3Q4cHF1N085M2NmR1QwbmVUOW1Mc01GLVU2TXdPMWliLWJocjNEX0RxVWZ4NjUxSVBXTnMwUWQwNGlBY1R3OGFPWQ?oc=5","date":"2019-09-29","type":"pipeline","source":"ACS Publications","summary":"Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility - ACS Publications","headline":"Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}